Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fondazione Arianna Anticoagulazione is an Italian non-profit research foundation focused on the study and improvement of anticoagulant therapies. The organization is best known for managing the START Registry (Survey on Anticoagulated Patients Register), an independent, large-scale observational study that collects real-world data on patients treated with anticoagulants. Its activities include promoting clinical research, providing medical education, and developing guidelines to enhance the safety and efficacy of treatments for thrombosis and related cardiovascular conditions. The foundation serves as a central hub for healthcare professionals to share clinical experiences and standardize anticoagulation management across Italy. By analyzing long-term outcomes of both traditional Vitamin K antagonists and direct oral anticoagulants, the foundation contributes significantly to evidence-based medicine in hematology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Arianna Anticoagulazione Foundation.